Weight-loss Surgery Answer for Type 2 Diabetics?

March 2008
Travel Medicine Advisor;Mar2008, Vol. 18 Issue 3, p1
The article highlights the findings of a clinical study in Australia which demonstrated that gastrointestinal tract surgery could be an effective approach for the management of type 2 diabetes. The study involved 60 type 2 diabetic patients with body mass index (BMI) of 30-40 and who were randomized to adjustable gastric banding surgery or conventional therapy. It mentions that the remission of the diabetes through average weight loss was achieved by 86% of patients in the surgical group and only 1% of the medical therapy patients.


Related Articles

  • Intensified treatment with insulin detemir improved glycemic control, weight loss.  // Endocrine Today;Oct2011, Vol. 9 Issue 10, p20 

    The article reports that a randomized trial has found that adding insulin detemir to a treatment regimen of metformin and liraglutide resulted to improved glycemic control and sustained weight loss for up to 52 weeks in patients with type 2 diabetes.

  • Can 15 LB reverse diabetes? Davis, James; R.M.D. // Cortlandt Forum;11/25/95, Vol. 8 Issue 11, p87 

    Answers the question on studies proving that small weight loss can reverse adult-onset diabetes mellitus. Indication of the little effect of a small amount of weight loss.

  • The Endocannabinoid System: A Promising Target for the Management of Type 2 Diabetes. Scheen, Andr� J. // Current Protein & Peptide Science;Feb2009, Vol. 10 Issue 1, p56 

    Type 2 diabetes is closely related to abdominal obesity and is generally associated with other cardiometabolic risk factors, resulting in a high incidence of cardiovascular complications. Several animal and human observations suggest that the endocannabinoid (EC) system is overactivated in...

  • Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries. Östenson, Claes-Göran; Matthaei, Stephan; Reaney, Matthew; Krarup, Thure; Guerci, Bruno; Kiljanski, Jacek; Salaun-Martin, Carole; Sapin, Hélène; Bruhn, David; Mathieu, Chantal; Theodorakis, Michael // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;Apr2013, Vol. 6, p171 

    Objective: The CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE therapy (CHOICE) study assessed time to, and reasons for, significant treatment change after patients with type 2 diabetes (T2DM) initiated their first injectable glucose-lowering therapy...

  • Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus. Kaushal, Shaveta; Singh, Harmanjit; Thangaraju, Pugazhenthan; Singh, Jasbir // North American Journal of Medical Sciences;Mar2014, Vol. 6 Issue 3, p107 

    Diabetes Mellitus continues to be a major non- communicable disease with global burden of 366 million at present and projected to increase to 439 to 552 million by 2030, India being the hub of diabetes. Sodium glucose transporter 2 (SGLT2) inhibitors presents a new class of anti-diabetic drugs...

  • Promising weight loss programme. Denby, Martin // New Zealand Doctor;6/6/2007, p25 

    The article stresses the importance of a weight loss programme for diabetic patients. The author says that lifestyle changes make a difference in weight loss. He reports that the Diabetes Prevention Program found that a 7% weight loss can lessen the onset of type 2 diabetes by 58%. He adds that...

  • Weight Loss in Type 2 Diabetic Patients. Pi-Sunyer, F. Xavier // Diabetes Care;Jun2005, Vol. 28 Issue 6, p1526 

    Explains the importance of weight loss in the treatment of type diabetic patients. Outcome of a combination of weight loss therapies in type 2 diabetic patients, reported by Redmon et al.; Reasons for the difficulty of losing weight for such patients; Adequacy of a behavioral modification...

  • PART 3: DIETARY AND LIFESTYLE FACTORS IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS. Boylan, Matthew // Journal of the Australian Traditional-Medicine Society;Jun2007, Vol. 13 Issue 2, p89 

    The importance of weight management as an essential non-pharmacological intervention in the treatment of type 2 diabetes mellitus is considered. Recommendations are made for appropriate ways to manage weight and to measure that management.

  • A Review of Exenatide in the Treatment of Type 2 Diabetes Mellitus. Samat, Aashish G.; Bhargava, Amit; Vasantha Reddy // Clinical Medicine Insights: Therapeutics;2010, Issue 2, p715 

    Diabetes Mellitus (DM) is a chronic disease, with a rapidly increasing worldwide incidence and prevalence. Diabetes accounts for 8% of the US population, according to the United States Centers for Disease Control and Prevention. In terms of individuals, this number comes to a staggering 24...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics